-
Je něco špatně v tomto záznamu ?
Hydrocephalus Caused by Primary Fourth Ventricle Outlet Obstruction: Our Experience and Literature Review
O. Krejčí, T. Krejčí, M. Mrůzek, Z. Večeřa, D. Šalounová, R. Lipina
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
- MeSH
- čtvrtá mozková komora * diagnostické zobrazování chirurgie MeSH
- diplopie etiologie MeSH
- dítě MeSH
- dospělí MeSH
- endoskopie MeSH
- hydrocefalus diagnostické zobrazování epidemiologie etiologie chirurgie MeSH
- intrakraniální hypertenze etiologie MeSH
- kojenec MeSH
- kraniotomie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- neurologické poruchy chůze etiologie MeSH
- novorozenec MeSH
- poruchy vědomí etiologie MeSH
- předškolní dítě MeSH
- retrospektivní studie MeSH
- senioři MeSH
- shunty pro odvod mozkomíšního moku MeSH
- ventrikulostomie MeSH
- výsledek terapie MeSH
- zvracení etiologie MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
OBJECTIVE: Primary fourth ventricle outlet obstruction (PFVOO) is a rare cause of hydrocephalus with an unclear etiopathogenesis, and thus, consensus regarding the recommended treatment protocol is lacking. This study aims to summarize current knowledge of this condition in the light of our own treatment experience. METHODS: Retrospective analysis was carried out of all patients treated for noncommunicating tetraventricular hydrocephalus between 2006 and 2019, from which a subgroup of patients with PFVOO was created. A literature review of PFVOO cases was also carried out. RESULTS: A total of 62 patients with PFVOO were discovered, of whom 8 were treated at our institution, representing 3.8% of our patients with noncommunicating hydrocephalus. Patients most commonly presented with headaches, gait disturbance, or symptoms of intracranial hypertension. The mean follow-up duration was 75.4 months among our patients and 29.9 months in the literature. Most patients (54.8%) were treated by endoscopic third ventriculostomy (ETV), with the remainder undergoing suboccipital craniotomy alone (17.7%) or in combination with shunt surgery (9.7%), or endoscopic magendieplasty (12.9%). Treatment failure was noted in 28.6% of ETVs and 9% of craniotomies. No failures were recorded after endoscopic magendieplasty. The risk of treatment failure was found to be significantly higher with ETV compared with other treatment modalities (P < 0.0005). CONCLUSIONS: Despite the fact that PFVOO can be defined as an obstructive hydrocephalus, there seems to be a higher risk of ETV failure in such cases. The alternative treatment modalities presented are still recommended. Confirmation of these findings requires a larger multicenter study.
Department of Neurosurgery University Hospital Ostrava Ostrava Czech Republic
Faculty of Medicine University of Ostrava Ostrava Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025928
- 003
- CZ-PrNML
- 005
- 20211026133353.0
- 007
- ta
- 008
- 211013s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.wneu.2021.01.008 $2 doi
- 035 __
- $a (PubMed)33444837
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Krejčí, Ondřej $u Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic
- 245 10
- $a Hydrocephalus Caused by Primary Fourth Ventricle Outlet Obstruction: Our Experience and Literature Review / $c O. Krejčí, T. Krejčí, M. Mrůzek, Z. Večeřa, D. Šalounová, R. Lipina
- 520 9_
- $a OBJECTIVE: Primary fourth ventricle outlet obstruction (PFVOO) is a rare cause of hydrocephalus with an unclear etiopathogenesis, and thus, consensus regarding the recommended treatment protocol is lacking. This study aims to summarize current knowledge of this condition in the light of our own treatment experience. METHODS: Retrospective analysis was carried out of all patients treated for noncommunicating tetraventricular hydrocephalus between 2006 and 2019, from which a subgroup of patients with PFVOO was created. A literature review of PFVOO cases was also carried out. RESULTS: A total of 62 patients with PFVOO were discovered, of whom 8 were treated at our institution, representing 3.8% of our patients with noncommunicating hydrocephalus. Patients most commonly presented with headaches, gait disturbance, or symptoms of intracranial hypertension. The mean follow-up duration was 75.4 months among our patients and 29.9 months in the literature. Most patients (54.8%) were treated by endoscopic third ventriculostomy (ETV), with the remainder undergoing suboccipital craniotomy alone (17.7%) or in combination with shunt surgery (9.7%), or endoscopic magendieplasty (12.9%). Treatment failure was noted in 28.6% of ETVs and 9% of craniotomies. No failures were recorded after endoscopic magendieplasty. The risk of treatment failure was found to be significantly higher with ETV compared with other treatment modalities (P < 0.0005). CONCLUSIONS: Despite the fact that PFVOO can be defined as an obstructive hydrocephalus, there seems to be a higher risk of ETV failure in such cases. The alternative treatment modalities presented are still recommended. Confirmation of these findings requires a larger multicenter study.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a shunty pro odvod mozkomíšního moku $7 D002557
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a poruchy vědomí $x etiologie $7 D003244
- 650 _2
- $a kraniotomie $7 D003399
- 650 _2
- $a diplopie $x etiologie $7 D004172
- 650 _2
- $a endoskopie $7 D004724
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a čtvrtá mozková komora $x diagnostické zobrazování $x chirurgie $7 D020546
- 650 _2
- $a neurologické poruchy chůze $x etiologie $7 D020233
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrocefalus $x diagnostické zobrazování $x epidemiologie $x etiologie $x chirurgie $7 D006849
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a intrakraniální hypertenze $x etiologie $7 D019586
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a ventrikulostomie $7 D014696
- 650 _2
- $a zvracení $x etiologie $7 D014839
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Krejčí, Tomáš $u Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Electronic address: tomas.krejci@fno.cz
- 700 1_
- $a Mrůzek, Michael $u Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Večeřa, Zdeněk $u Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Šalounová, Dana $u Department of Mathematical Methods in Economy, VSB-Technical University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Lipina, Radim $u Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 773 0_
- $w MED00167613 $t World neurosurgery $x 1878-8769 $g Roč. 148, č. - (2021), s. e425-e435
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33444837 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133359 $b ABA008
- 999 __
- $a ok $b bmc $g 1714821 $s 1146435
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 148 $c - $d e425-e435 $e 20210112 $i 1878-8769 $m World neurosurgery $n World Neurosurg $x MED00167613
- LZP __
- $a Pubmed-20211013